MedTrace Logo

Remifentanil and Fentanyl in Dental Surgery (REFEDS)

NCT02619032 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2015-12-02

No results posted yet for this study

Summary

This study was a prospective comparative study. The purpose of this study was to investigate the hypothesis whether remifentanil compared to fentanyl can induce less inflammatory and stress response to the day-case dental surgery in Persons with special needs (PSN). Secondary aims were to investigate comparatively their effect on patients intraoperative hemodynamic response and postoperative analgesia.

Conditions

  • Postoperative Pain

Interventions

DRUG

Remifentanil

Intraoperative continuous infusion of remifenatanil. Remifentanil infusion was interrupted upon completion of surgical intervention.

DRUG

Fentanyl

Fentanyl 50 μg iv bolus at the induction of anesthesia and before the start of surgery.

Sponsors & Collaborators

  • Asklepieion Voulas General Hospital

    collaborator OTHER_GOV

  • Attikon Hospital

    lead OTHER

Principal Investigators

  • Eirini A Sklika, Consultant · Asklepeion Voulas General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2009-07-31
Completion
2009-09-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02619032 on ClinicalTrials.gov